1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Venous Thromboembolism Therapy Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Venous Thromboembolism Therapy by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Venous Thromboembolism Therapy by Country/Region, 2020, 2024 & 2031
2.2 Venous Thromboembolism Therapy Segment by Type
2.2.1 Non-Segmented Pneumatic Compression Pumps
2.2.2 Segmented Pneumatic Compression Pumps without Gradient
2.3 Venous Thromboembolism Therapy Sales by Type
2.3.1 Global Venous Thromboembolism Therapy Sales Market Share by Type (2020-2025)
2.3.2 Global Venous Thromboembolism Therapy Revenue and Market Share by Type (2020-2025)
2.3.3 Global Venous Thromboembolism Therapy Sale Price by Type (2020-2025)
2.4 Venous Thromboembolism Therapy Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 Others
2.5 Venous Thromboembolism Therapy Sales by Application
2.5.1 Global Venous Thromboembolism Therapy Sale Market Share by Application (2020-2025)
2.5.2 Global Venous Thromboembolism Therapy Revenue and Market Share by Application (2020-2025)
2.5.3 Global Venous Thromboembolism Therapy Sale Price by Application (2020-2025)
3 Global Venous Thromboembolism Therapy by Company
3.1 Global Venous Thromboembolism Therapy Breakdown Data by Company
3.1.1 Global Venous Thromboembolism Therapy Annual Sales by Company (2020-2025)
3.1.2 Global Venous Thromboembolism Therapy Sales Market Share by Company (2020-2025)
3.2 Global Venous Thromboembolism Therapy Annual Revenue by Company (2020-2025)
3.2.1 Global Venous Thromboembolism Therapy Revenue by Company (2020-2025)
3.2.2 Global Venous Thromboembolism Therapy Revenue Market Share by Company (2020-2025)
3.3 Global Venous Thromboembolism Therapy Sale Price by Company
3.4 Key Manufacturers Venous Thromboembolism Therapy Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Venous Thromboembolism Therapy Product Location Distribution
3.4.2 Players Venous Thromboembolism Therapy Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2025)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Venous Thromboembolism Therapy by Geographic Region
4.1 World Historic Venous Thromboembolism Therapy Market Size by Geographic Region (2020-2025)
4.1.1 Global Venous Thromboembolism Therapy Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Venous Thromboembolism Therapy Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Venous Thromboembolism Therapy Market Size by Country/Region (2020-2025)
4.2.1 Global Venous Thromboembolism Therapy Annual Sales by Country/Region (2020-2025)
4.2.2 Global Venous Thromboembolism Therapy Annual Revenue by Country/Region (2020-2025)
4.3 Americas Venous Thromboembolism Therapy Sales Growth
4.4 APAC Venous Thromboembolism Therapy Sales Growth
4.5 Europe Venous Thromboembolism Therapy Sales Growth
4.6 Middle East & Africa Venous Thromboembolism Therapy Sales Growth
5 Americas
5.1 Americas Venous Thromboembolism Therapy Sales by Country
5.1.1 Americas Venous Thromboembolism Therapy Sales by Country (2020-2025)
5.1.2 Americas Venous Thromboembolism Therapy Revenue by Country (2020-2025)
5.2 Americas Venous Thromboembolism Therapy Sales by Type
5.3 Americas Venous Thromboembolism Therapy Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Venous Thromboembolism Therapy Sales by Region
6.1.1 APAC Venous Thromboembolism Therapy Sales by Region (2020-2025)
6.1.2 APAC Venous Thromboembolism Therapy Revenue by Region (2020-2025)
6.2 APAC Venous Thromboembolism Therapy Sales by Type
6.3 APAC Venous Thromboembolism Therapy Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Venous Thromboembolism Therapy by Country
7.1.1 Europe Venous Thromboembolism Therapy Sales by Country (2020-2025)
7.1.2 Europe Venous Thromboembolism Therapy Revenue by Country (2020-2025)
7.2 Europe Venous Thromboembolism Therapy Sales by Type
7.3 Europe Venous Thromboembolism Therapy Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Venous Thromboembolism Therapy by Country
8.1.1 Middle East & Africa Venous Thromboembolism Therapy Sales by Country (2020-2025)
8.1.2 Middle East & Africa Venous Thromboembolism Therapy Revenue by Country (2020-2025)
8.2 Middle East & Africa Venous Thromboembolism Therapy Sales by Type
8.3 Middle East & Africa Venous Thromboembolism Therapy Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Venous Thromboembolism Therapy
10.3 Manufacturing Process Analysis of Venous Thromboembolism Therapy
10.4 Industry Chain Structure of Venous Thromboembolism Therapy
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Venous Thromboembolism Therapy Distributors
11.3 Venous Thromboembolism Therapy Customer
12 World Forecast Review for Venous Thromboembolism Therapy by Geographic Region
12.1 Global Venous Thromboembolism Therapy Market Size Forecast by Region
12.1.1 Global Venous Thromboembolism Therapy Forecast by Region (2026-2031)
12.1.2 Global Venous Thromboembolism Therapy Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Venous Thromboembolism Therapy Forecast by Type
12.7 Global Venous Thromboembolism Therapy Forecast by Application
13 Key Players Analysis
13.1 Medtronic
13.1.1 Medtronic Company Information
13.1.2 Medtronic Venous Thromboembolism Therapy Product Portfolios and Specifications
13.1.3 Medtronic Venous Thromboembolism Therapy Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Medtronic Main Business Overview
13.1.5 Medtronic Latest Developments
13.2 Boston Scientific
13.2.1 Boston Scientific Company Information
13.2.2 Boston Scientific Venous Thromboembolism Therapy Product Portfolios and Specifications
13.2.3 Boston Scientific Venous Thromboembolism Therapy Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Boston Scientific Main Business Overview
13.2.5 Boston Scientific Latest Developments
13.3 Stryker
13.3.1 Stryker Company Information
13.3.2 Stryker Venous Thromboembolism Therapy Product Portfolios and Specifications
13.3.3 Stryker Venous Thromboembolism Therapy Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Stryker Main Business Overview
13.3.5 Stryker Latest Developments
13.4 AngioDynamics
13.4.1 AngioDynamics Company Information
13.4.2 AngioDynamics Venous Thromboembolism Therapy Product Portfolios and Specifications
13.4.3 AngioDynamics Venous Thromboembolism Therapy Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 AngioDynamics Main Business Overview
13.4.5 AngioDynamics Latest Developments
13.5 Cook Medical
13.5.1 Cook Medical Company Information
13.5.2 Cook Medical Venous Thromboembolism Therapy Product Portfolios and Specifications
13.5.3 Cook Medical Venous Thromboembolism Therapy Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Cook Medical Main Business Overview
13.5.5 Cook Medical Latest Developments
13.6 Cardinal Health
13.6.1 Cardinal Health Company Information
13.6.2 Cardinal Health Venous Thromboembolism Therapy Product Portfolios and Specifications
13.6.3 Cardinal Health Venous Thromboembolism Therapy Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Cardinal Health Main Business Overview
13.6.5 Cardinal Health Latest Developments
13.7 DJO Global
13.7.1 DJO Global Company Information
13.7.2 DJO Global Venous Thromboembolism Therapy Product Portfolios and Specifications
13.7.3 DJO Global Venous Thromboembolism Therapy Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 DJO Global Main Business Overview
13.7.5 DJO Global Latest Developments
13.8 Philips Holding
13.8.1 Philips Holding Company Information
13.8.2 Philips Holding Venous Thromboembolism Therapy Product Portfolios and Specifications
13.8.3 Philips Holding Venous Thromboembolism Therapy Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Philips Holding Main Business Overview
13.8.5 Philips Holding Latest Developments
13.9 ArjoHuntleigh AB
13.9.1 ArjoHuntleigh AB Company Information
13.9.2 ArjoHuntleigh AB Venous Thromboembolism Therapy Product Portfolios and Specifications
13.9.3 ArjoHuntleigh AB Venous Thromboembolism Therapy Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 ArjoHuntleigh AB Main Business Overview
13.9.5 ArjoHuntleigh AB Latest Developments
13.10 Argon Medical Devices
13.10.1 Argon Medical Devices Company Information
13.10.2 Argon Medical Devices Venous Thromboembolism Therapy Product Portfolios and Specifications
13.10.3 Argon Medical Devices Venous Thromboembolism Therapy Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Argon Medical Devices Main Business Overview
13.10.5 Argon Medical Devices Latest Developments
13.11 DaeSung Maref
13.11.1 DaeSung Maref Company Information
13.11.2 DaeSung Maref Venous Thromboembolism Therapy Product Portfolios and Specifications
13.11.3 DaeSung Maref Venous Thromboembolism Therapy Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 DaeSung Maref Main Business Overview
13.11.5 DaeSung Maref Latest Developments
13.12 ALN Implants Chirurgicaux
13.12.1 ALN Implants Chirurgicaux Company Information
13.12.2 ALN Implants Chirurgicaux Venous Thromboembolism Therapy Product Portfolios and Specifications
13.12.3 ALN Implants Chirurgicaux Venous Thromboembolism Therapy Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 ALN Implants Chirurgicaux Main Business Overview
13.12.5 ALN Implants Chirurgicaux Latest Developments
13.13 Lifetech Scientific
13.13.1 Lifetech Scientific Company Information
13.13.2 Lifetech Scientific Venous Thromboembolism Therapy Product Portfolios and Specifications
13.13.3 Lifetech Scientific Venous Thromboembolism Therapy Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Lifetech Scientific Main Business Overview
13.13.5 Lifetech Scientific Latest Developments
14 Research Findings and Conclusion
| ※参考情報 静脈血栓塞栓症（Venous Thromboembolism, VTE）は、静脈内に血栓が形成される現象を指し、その血栓が血流によって移動し、肺などの主要な臓器の血管を塞ぐことによって、深部静脈血栓症（DVT）や肺血栓塞栓症（PE）を引き起こすことがあります。この病態は、感染症や外科手術、長時間の安静などによって引き起こされることが多く、適切な治療が行われない場合、重篤な合併症や死亡に至る可能性があります。 静脈血栓塞栓症の特徴としては、第一にその発生機序があります。血栓形成には様々な因子が関与しており、一般的には血液の凝固、血流の停滞、血管壁の損傷の3つの要素が重要です。これをウィルスティーリウスの法則と呼びます。特に手術後や長時間の移動の際には、血流が滞りやすくなるため、リスクが高まります。また、特定の遺伝的要因や生活習慣、肥満、妊娠なども病気のリスクを増加させる要因となります。 治療にはいくつかの選択肢があり、抗凝固療法が中心となります。抗凝固薬には、ヘパリン製剤やワルファリン、さらには新しい経口抗凝固薬（NOAC）などが含まれます。ヘパリンは急性期の治療に主に使用される薬剤で、即効性がありますが、投与方法が静脈内であったり皮下注射であったりと、患者にとっての利便性が低い場合があります。一方、ワルファリンは経口薬として広く使用されているものの、服薬管理が難しいため定期的な血液検査が必要です。最近では、NOACが登場し、服薬管理が容易で、定期的なモニタリングが不要なため人気がありますが、特有の副作用やリスクも存在します。 血栓形成を予防するための方法には、機械的予防があり、弾性ストッキングや間欠的空気圧迫装置（IPC）が利用されることがあります。これにより、下肢の血流を改善し、血栓形成のリスクを低下させることができます。特に入院患者や外科手術を受ける患者に対しては、入院中の早期の歩行が推奨されることがありますが、場合によっては患者個々の状況に応じたアプローチが求められます。 静脈血栓塞栓症の診断には、臨床症状の評価や血液検査、画像診断が用いられます。DVTの診断には、超音波検査が広く用いられ、血管内の血栓の有無を調べます。また、PEの診断にはCT肺動脈造影が最も一般的であり、ここでは肺動脈の異常を確認することができます。他にも、Dダイマーの測定が行われることがあり、これは血栓が形成されている際に生成される物質で、特定の基準を超えるとVTEの可能性を示唆することがあります。 関連技術としては、最小侵襲手術や血管内治療技術の進展が挙げられます。ステントやカテーテルを使用した治療法は、特定の症例において血栓の物理的な除去を行うことが可能であり、患者への負担を軽減することが期待されています。また、リモートモニタリング技術の発展により、血栓症の予防や治療の際に患者の状態をリアルタイムで把握し、必要に応じた介入が行えるようになることも注目されています。 さらに、静脈血栓塞栓症の研究は進んでおり、遺伝的要因の解明や新たな抗凝固薬、予防策の開発が行われています。生物学的マーカーやリスク因子の再評価が進んでおり、個々の患者に最適な治療法を提供するための努力が続けられています。 このように、静脈血栓塞栓症の治療は多岐にわたり、患者さんの状態やリスクに応じた適切な戦略が求められます。今後も新たな技術の進展や研究成果が期待され、より良い治療法の確立が目指されています。静脈血栓塞栓症の理解を深め、適切な予防と治療を行うことで、患者さんの安全を守り、健康な生活を送るための支援を行うことが重要です。 |
*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
